Toshiki Tanikawa

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

A phase I study of enfortumab vedotin in Japanese patients with locally advanced or metastatic urothelial carcinoma

Shunji Takahashi, Motohide Uemura, Tomokazu Kimura et al. · Investigational New Drugs · 2019 · 77 citations · Full text

Pinpoint targeted immunosuppression: anti‐CD20/MMF desensitization with anti‐CD25 in successful ABO‐incompatible kidney transplantation without splenectomy

Kazuhide Saito, Yuki Nakagawa, Michihiro Suwa et al. · Xenotransplantation · 2006 · 38 citations · Full text

Immunohistochemical Detection of Intercellular Adhesion Molecule-1 (ICAM-1) and Major Histocompatibility Complex Class I Antigens in Seminoma

Yoshihiko Tomita, Motohiko Kimura, Toshiki Tanikawa et al. · The Journal of Urology · 1993 · 34 citations

Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes

Kazuhiro Kobayashi, Toshihiro Saito, Yasuo Kitamura et al. · International Journal of Urology · 2015 · 30 citations · Full text